An aesthetic doctor in Singapore injected a patient with more than three times the annual limit of dermal fillers in a single session, triggering 19 months of facial pain, nerve damage, and subsequent regulatory penalties, The Straits Times reported.
Following a review of the case, an interim orders committee (IOC) prohibited Dr. Isaac Wong Kai Jie from administering dermal fillers to any patient. Dr. Wong, the founder and medical director of The Artisan Clinic at Paragon shopping mall, has appealed the IOC decision to the High Court.
Treatment Timeline and 19 Months of Severe Complications
The patient first visited Dr. Wong on April 1, 2023, seeking aesthetic treatments, according to decision grounds published on the Singapore Medical Council (SMC) website on Oct 7. During that initial appointment, Dr. Wong administered a total dosage of 7ml of dermal fillers into her face. Packaging labels for the specific product designated 2ml as the maximum annual dosage.
Immediately following the procedure, the patient reported acute pain on the left side of her face. Dr. Wong identified visible discolouration on her left cheek and diagnosed a vascular occlusion, a dangerous blockage of a blood vessel. To reverse the blockage, he injected hyaluronidase—an enzyme designed to break down hyaluronic acid—into her face multiple times.
Between April 2, 2023, and Oct 8, 2024, the patient attended repeated follow-up consultations at the clinic. Throughout this period, Dr. Wong continued administering treatments, including hyaluronidase, growth factors, and steroids, to manage her persistent pain, neuralgia, and neuritis. In June 2023, a colleague visiting the clinic expressed uncertainty to Dr. Wong regarding whether continued hyaluronidase injections would help the patient’s condition.
Seeking alternative relief, the patient eventually consulted an ear, nose, and throat surgeon, an anaesthesiologist, and a general practitioner. In August 2024, she underwent nerve surgery to address her persistent facial pain. She subsequently filed a complaint with the SMC in November 2024, stating that the continuous pain lasted at least 19 months, caused a 20kg weight loss, spiked her blood pressure, and forced her out of her job due to the toll on her health and mental well-being.
Regulatory Penalties and High Court Appeal Scheduled
An independent complaints committee reviewed the case and referred it to the SMC in January 2026 to establish an interim orders committee. On Aug 26, the four-member IOC—chaired by Institute of Mental Health psychiatrist and senior consultant Lee Cheng—issued restriction orders against Dr. Wong. The committee concluded that the conditions were necessary for the protection of the public. Decision grounds revealed that five separate complaints alleging dermal filler overdosing and adverse effects have been filed against Dr. Wong.
Dr. Wong appealed the IOC restrictions to the High Court. He disputed the 2ml annual limit, citing a November 2025 manufacturer statement indicating a recommended single-session dose of up to 12ml based on a toxicological report. The SMC countered that the manufacturer updated its labeling in March 2026, emphasizing that Dr. Wong knowingly exceeded the 2ml regulatory limit enforced in Singapore at the time of the 2023 incident.
Furthermore, Dr. Wong defended his complication rate, stating he administered over 19,600 filler injections between 2018 and 2026 with only one occlusion case. He noted that his incidence rate of 0.0051% falls at the lower end of the 0.0024% to 0.04% range cited in an expert report by a veteran plastic surgeon. While the SMC criticized Dr. Wong for failing to promptly refer the patient to a specialist, Dr. Wong maintained that he did refer her to a doctor in April 2023 for hyperbaric oxygen therapy to treat the occlusion.
Keep reading